The University of Kansas School of Medicine-Wichita Center for Clinical Research has resumed leading the local effort of a nationwide clinical trial brought 
through the COVID-19 Prevention Network testing the COVID-19 vaccine AZD1222, developed by Oxford University and purchased by AstraZeneca.
Locally, the vaccine will be available at KU Wichita Center for Clinical Research and its mobile unit, which will travel to high-risk areas in Wichita and the surrounding region. There is an overall goal to recruit 1,200 participants in Kansas, with 200 being enrolled in Wichita.
For more information and to learn how to be considered for the trial, read the full story.
Contact KU Wichita Internal Medicine
The internal medicine specialists at KU Wichita Internal Medicine are dedicated to providing the highest quality of care to patients throughout the Wichita, KS area. Contact our primary care office for more information today!